MBT 1805
Alternative Names: MBT-1805Latest Information Update: 03 Nov 2020
At a glance
- Originator Beijing JK HuaYuan Med Tech Company LTD
- Class Hepatoprotectants
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor delta agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Primary biliary cirrhosis